Richard Král, Saneca Pharma CEO
Contract development and manufacturing organization (CDMO) Saneca Pharma has announced the appointment of its new CEO, Richard Král.
Richard, who has been the sales and marketing director at Saneca for almost three years, has previously worked for GlaxoSmithKline and Zentiva Group across the Central and Eastern Europe (CEE) and the Commonweath of Independent States (CIS) regions and has over 17 years’ experience in the pharmaceutical sector and FMCG.
As CEO, he will be responsible for implementing Saneca’s business growth strategy, driving operational efficiency and ensuring effective project delivery across the business.
“I am delighted to be appointed as CEO of Saneca,” Richard Král said. “Over the last three years I have developed a comprehensive understanding of the company and I am looking forward to continuing to drive its success and establishing Saneca as the go-to CDMO in Europe.